Signal from the log
Enginprime Medical
12 M$ · Series A · China · Medtech
Enginprime Medical développe OpusOne, une pompe cardiaque percutanée à hélice repliable de 8 French, destinée à soutenir le cœur pendant une intervention. Série A de 12 M$ menée par Qiming Venture Partners.
Verified
Announced on , logged by the watch of 18 August 2026.
- Operation
- Funding round
- Announced amount
- 12 M$
- Stage
- Series A
- Country
- China
- Sector
- Medtech
What the log says
Editorial note, in French
Communiqué ouvert, montant relu et fonds nommés.
The investors
Led by Qiming Venture Partners
Provenance
Source prnewswire
Logged on 18 August 2026
Description Written in French during the watch run. Written during the watch run, after reading the issuer's press release or the source article.
Verification Amounts and fund names were double checked against the issuer's press release or an official filing.
What this status means
Verified The press release was opened: amount double checked, funds named. The article remains to be written.
The rule A signal is never removed from the log. A round set aside stays readable with its reason, because a collection you cannot reread is a collection you cannot correct.